Scientists in France pinpoint why STING pathway hasn't been harnessed for cancer therapy yet
Deep within the cellular landscape, a quiet failure was taking place, impeding a potentially successful form of cancer treatment. For years, scientists hoped an essential part of the innate immune system that detects foreign DNA in cellular cytoplasm—the STING pathway—could be harnessed for use in cancer immunotherapy.
Scientists in France have uncovered the reasons why the STING pathway has not been successfully utilized in cancer therapy. Despite its potential, harnessing the innate immune system pathway called STING proved challenging in clinical settings. Researchers at the French National Institute of Health and Medical Research (INSERM) discovered two critical factors that hinder the effectiveness of the STING pathway: defects in autophagy within dendritic cells and an influx of immunosuppressive neutrophils.
Autophagy, a natural cellular process of degradation and recycling, plays a crucial role in STING-based immunotherapy. However, when autophagy is impaired, the molecular alarm system (cGAMP) fails to effectively recruit killer T cells to fight tumor cells. The study found that the presence of neutrophils, which accumulate in tumors and their surrounding lymph nodes, contributed to this failure.
These neutrophils, instead of attacking the cancer, released a suppressive signal that blinded killer T cells. The findings challenge the previously held belief that STING-based therapy relies solely on type I interferon signaling. Instead, successful therapy requires intact autophagy in dendritic cells. The researchers suggest that addressing these factors could unlock the potential of intratumoral STING activation for cancer treatment.
The study was conducted in a mouse model and demonstrated that targeting dendritic cell autophagy and neutrophil influx could improve the efficacy of STING immunotherapy.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
